GSTT1 andGSTM1 gene polymorphisms and gastric cancer in a high-risk italian population

2005 ◽  
Vol 115 (2) ◽  
pp. 284-289 ◽  
Author(s):  
Domenico Palli ◽  
Calogero Saieva ◽  
Simonetta Gemma ◽  
Giovanna Masala ◽  
Maria Jesus Gomez-Miguel ◽  
...  
2005 ◽  
Vol 100 (9) ◽  
pp. 1941-1948 ◽  
Author(s):  
D. Palli ◽  
C. Saieva ◽  
I. Luzzi ◽  
G. Masala ◽  
S. Topa ◽  
...  

Helicobacter ◽  
2016 ◽  
Vol 21 (6) ◽  
pp. 523-535 ◽  
Author(s):  
Souvik Ghatak ◽  
Ravi Prakash Yadav ◽  
Freda Lalrohlui ◽  
Payel Chakraborty ◽  
Soumee Ghosh ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e87467 ◽  
Author(s):  
Juozas Kupcinskas ◽  
Thomas Wex ◽  
Alexander Link ◽  
Marcis Leja ◽  
Indre Bruzaite ◽  
...  

2021 ◽  
Vol 24 (3) ◽  
pp. 680-690
Author(s):  
Michiel C. Mommersteeg ◽  
Stella A. V. Nieuwenburg ◽  
Wouter J. den Hollander ◽  
Lisanne Holster ◽  
Caroline M. den Hoed ◽  
...  

Abstract Introduction Guidelines recommend endoscopy with biopsies to stratify patients with gastric premalignant lesions (GPL) to high and low progression risk. High-risk patients are recommended to undergo surveillance. We aimed to assess the accuracy of guideline recommendations to identify low-risk patients, who can safely be discharged from surveillance. Methods This study includes patients with GPL. Patients underwent at least two endoscopies with an interval of 1–6 years. Patients were defined ‘low risk’ if they fulfilled requirements for discharge, and ‘high risk’ if they fulfilled requirements for surveillance, according to European guidelines (MAPS-2012, updated MAPS-2019, BSG). Patients defined ‘low risk’ with progression of disease during follow-up (FU) were considered ‘misclassified’ as low risk. Results 334 patients (median age 60 years IQR11; 48.7% male) were included and followed for a median of 48 months. At baseline, 181/334 (54%) patients were defined low risk. Of these, 32.6% were ‘misclassified’, showing progression of disease during FU. If MAPS-2019 were followed, 169/334 (51%) patients were defined low risk, of which 32.5% were ‘misclassified’. If BSG were followed, 174/334 (51%) patients were defined low risk, of which 32.2% were ‘misclassified’. Seven patients developed gastric cancer (GC) or dysplasia, four patients were ‘misclassified’ based on MAPS-2012 and three on MAPS-2019 and BSG. By performing one additional endoscopy 72.9% (95% CI 62.4–83.3) of high-risk patients and all patients who developed GC or dysplasia were identified. Conclusion One-third of patients that would have been discharged from GC surveillance, appeared to be ‘misclassified’ as low risk. One additional endoscopy will reduce this risk by 70%.


2009 ◽  
Vol 40 (1-2) ◽  
pp. 26-32 ◽  
Author(s):  
Manzoor A. Malik ◽  
Rohit Upadhyay ◽  
Rama D. Mittal ◽  
Showket A. Zargar ◽  
Dinesh R. Modi ◽  
...  

2002 ◽  
Vol 34 (1) ◽  
pp. 22-28 ◽  
Author(s):  
B. Riecken ◽  
R. Pfeiffer ◽  
J.L. Ma ◽  
M.L. Jin ◽  
J.Y. Li ◽  
...  

2008 ◽  
Vol 247 (4) ◽  
pp. 714-715 ◽  
Author(s):  
Dimosthenis Ziogas ◽  
Georgios Baltogiannis ◽  
Michael Fatouros ◽  
Dimitrios H. Roukos
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document